Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Liver transplant showdown: which method works best for colon cancer patients?

NCT ID NCT06698146

First seen Feb 19, 2026 · Last updated Jun 22, 2026 · Updated 12 times

Summary

This study looks at different ways to perform a liver transplant in people whose colorectal cancer has spread to the liver and cannot be removed by surgery. Researchers will compare living versus deceased donor transplants, whole versus split organs, and one-stage versus two-stage procedures. They will track survival, recovery, and complications over one year. The goal is to find out which method works best for these patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Northwestern University-Comprehensive Transplant Center

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

liver transplant (living or deceased donor, whole or split organ, one-stage or two-stage procedure)

What this could lead to

If successful, this study could help identify the best liver transplant approach for people with colorectal cancer that has spread to the liver, potentially improving survival and recovery.

What could go wrong

This is an observational registry study, not a treatment trial, so it won't test a new therapy. Results may not apply to all patients, and liver transplant carries serious risks like rejection and infection.

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm metastasis from malignant tumor of colon

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.